Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: Results of an experimental study

Supportive Care in Cancer

Volumn 21, Issue 3, 2013, Pages 811-817

  Yavas, Guler ^a   Yavas, Cagdas ^b   Acar, Hilal ^a   Toy, Hatice ^a   Yuce, Deniz ^c   Ata, Ozlem ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b KONYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Anastrozole; Letrozole; Pulmonary toxicity; Radiotherapy; Tamoxifen

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; LETROZOLE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL STUDY; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; INFLAMMATION; LUNG CONGESTION; LUNG FIBROSIS; LUNG PERFUSION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INDUCED PULMONARY FIBROSIS; RAT; SCORING SYSTEM;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE INHIBITORS; COMBINED MODALITY THERAPY; FEMALE; NITRILES; PULMONARY FIBROSIS; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; TAMOXIFEN; TRIAZOLES;

EID: 84874111364     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1584-7     Document Type: Article

References (30)

1. Graves PR, Siddiqui F, Anscher MS, Movsas B (2010) Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol 20:201-207
2. Kocak Z, Evans ES, Zhou SM (2005) Challenges in defining radiation pneumonitis in patients with lung cancer. Int J Radiat Oncol Biol Phys 62:635-638
3. Trott KR, Herrmann T, Kasper M (2004) Target cells in radiation pneumopathy. Int J Radiat Oncol Biol Phys 58(2):463-469
4. Kasper M, Haroske G (1996) Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. Histol Histopathol 11:463-483
5. Fleckenstein K, Zgonjanin L, Chen L (2007) Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int J Radiat Oncol Biol Phys 68:196-204
6. Chen Y, Williams J, Ding I et al (2002) Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12:26-33
7. Jordan VC (2004) Selective estrogen receptor modulation: concept and consequences in cancer. Cancer Cell 5:207-213
8. Bese NS, Umay C, Yildirim S, Ilvan S, Dirican A, Salar S et al (2006) The effects of tamoxifen on radiation-induced pulmonary fibrosis in Wistar albino rats: results of an experimental study. Breast 15:456-460
9. Koc M, Polat P, Suma S (2002) Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients. Radiother Oncol 64:171-175
10. Huang E-Y, Wang C-J, Chen H-C et al (2000) Multivariate analysis of pulmonary fibrosis after electron beam irradiation for postmastectomy chest wall and regional lypmhatics: evidence for non-dosimetric factors. Radiother Oncol 57:91-96
11. Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J (1996) Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 88:918-922
12. Ashcroft T, Simpson JM, Timbrelli V (1988) Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41:467-470
13. Osborne C, Boldt D, Clark G et al (1983) Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 43:3583-3585
14. Wazer D, Tercilla O, Lin P et al (1989) Modulation in the radiosensitivity of MCF-7 human breast carcinoma cells by 17-estradiol and tamoxifen. Br J Radiol 62:1079-1083
15. Paulsen G, Strickert T, Marthinsen A et al (1996) Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Acta Oncol 35:1011-1019
16. Sarkaria J, Miller E, Parker C et al (1994) 4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro. Breast Cancer Res Treat 30:159-165
17. Ellis P, Saccani-Jotti G, Clarke R et al (1997) Introduction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int J Cancer 72:608-613
18. Whelan T, Levine M (2005) Radiation therapy and tamoxifen: concurrent or sequential? That is the question. J Clin Oncol 23(1):1-4
19. Azria D, Larbouret C, Cunat S et al (2005) Letrozole sensitizes breast cancer cells to ionizing radiation. Breast Cancer Res 7(1):R156-R163
20. Brenner DJ (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18(4):234-239
21. Baum M, Buzdar A, Cuzick J et al (2003) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 98:1802-1810
22. Howell A, Cuzick J, Baum M et al (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365:60-62
23. Forbes JF, Cuzick J, Buzdar A et al (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9:45-53
24. Buzdar A, Howell A, Cuzick J et al (2006) Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 7:633-643
25. Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF, ATAC/LATTE investigators (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135-1141
26. ATAC Trialists' Group (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. Lancet 359:2131-2139
27. Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J et al (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081-1092
28. Goss PE, Hadji P, Subar M, Abreu P, Thomsen T, Banke-Bochita J (2007) Effects of steroidal and non-steroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women. Breast Cancer Res 9(4):R52
29. Love RR, Barden HS, Mazess RB, Epstein S, Chappell RJ (1994) Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years. Arch Intern Med 154:2585-2588
30. Bese NS, Umay C, Serdengecti S, Kepil N, Sut N, Altug T, Ober A (2010) The impact of trastuzumab on radiation-induced pulmonary fibrosis: results of an experimental study. Med Oncol 27(4):1415-1419